{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:02:14Z","timestamp":1777471334866,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Austrian Science FundAustrian Science Fund (FWF)","award":["F3506"],"award-info":[{"award-number":["F3506"]}]},{"name":"Austrian Science FundAustrian Science Fund (FWF)","award":["W1232"],"award-info":[{"award-number":["W1232"]}]},{"DOI":"10.13039\/501100001822","name":"Austrian Academy of Sciences","doi-asserted-by":"crossref","award":["2014-2016"],"award-info":[{"award-number":["2014-2016"]}],"id":[{"id":"10.13039\/501100001822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.neuint.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:02:07Z","timestamp":1537574527000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["\u201cPolytox\u201d synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux"],"prefix":"10.1016","volume":"123","author":[{"given":"Felix P.","family":"Mayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-9836","authenticated-orcid":false,"given":"Diethart","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Holy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette C.","family":"Daws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald H.","family":"Sitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2018.09.008_bib1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","article-title":"Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain","volume":"50","author":"Amphoux","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2018.09.008_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/qjmed\/hcs219","article-title":"Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances","volume":"106","author":"Archer","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.neuint.2018.09.008_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15563650.2014.885982","article-title":"Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances","volume":"52","author":"Archer","year":"2014","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuint.2018.09.008_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/npp.2015.260","article-title":"Abuse of new psychoactive substances: threats and solutions","volume":"41","author":"Baumann","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.09.008_bib5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.09.008_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.09.008_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-018-4962-0","article-title":"Is the 3,4-methylendioxypyrovalerone\/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect\/concentration relationships","author":"Benturquia","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuint.2018.09.008_bib8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/bph.12061","article-title":"Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter","volume":"168","author":"Cameron","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.09.008_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2014.09.008","article-title":"Role of organic cation transporters (OCTs) in the brain","volume":"146","author":"Courousse","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2018.09.008_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2008.10.004","article-title":"Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy","volume":"121","author":"Daws","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2018.09.008_bib11","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order","volume":"Vol. 76","author":"Drug Enforcement Administration","year":"2011"},{"key":"10.1016\/j.neuint.2018.09.008_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2018.09.008_bib13","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1523\/JNEUROSCI.4559-08.2009","article-title":"Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3","volume":"29","author":"Egana","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.09.008_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1523\/JNEUROSCI.2796-07.2008","article-title":"Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function","volume":"28","author":"Erreger","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.09.008_bib15","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1523\/JNEUROSCI.0570-06.2006","article-title":"Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission","volume":"26","author":"Gasser","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.09.008_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cne.21921","article-title":"Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain","volume":"512","author":"Gasser","year":"2009","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2018.09.008_bib17","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00429-016-1315-9","article-title":"Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice","volume":"222","author":"Gasser","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuint.2018.09.008_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","article-title":"Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3","volume":"136","author":"Hayer-Zillgen","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.09.008_bib19","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(16)30258-6","article-title":"Mephedrone use is increasing in London","volume":"387","author":"Hockenhull","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2018.09.008_bib20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.neuint.2018.09.008_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.forsciint.2011.03.015","article-title":"New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland","volume":"210","author":"Kriikku","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuint.2018.09.008_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2018.09.008_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.2002.021170","article-title":"Organic cation transporter mRNA and function in the rat superior cervical ganglion","volume":"543","author":"Kristufek","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuint.2018.09.008_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \"Ecstasy\") are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.09.008_bib25","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.forsciint.2010.12.014","article-title":"A case of extreme agitation and death after the use of mephedrone in The Netherlands","volume":"206","author":"Lusthof","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuint.2018.09.008_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/anatox\/35.3.188","article-title":"Mephedrone (4-methylmethcathinone)-related deaths","volume":"35","author":"Maskell","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuint.2018.09.008_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00424-013-1335-8","article-title":"The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3","volume":"466","author":"Massmann","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuint.2018.09.008_bib28","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1111\/bph.13547","article-title":"Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters","volume":"173","author":"Mayer","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.09.008_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/7854_2016_63","article-title":"Application of a combined approach to identify new psychoactive street drugs and Decipher their mechanisms at monoamine transporters","volume":"32","author":"Mayer","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuint.2018.09.008_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-018-0053-5","article-title":"An unsuspected role for organic cation transporter 3 in the actions of amphetamine","author":"Mayer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.09.008_bib31","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00204-016-1812-x","article-title":"New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics","volume":"90","author":"Meyer","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuint.2018.09.008_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug \"bath salts\" containing 3,4-Methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.neuint.2018.09.008_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2015.03.004","article-title":"The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter","volume":"755","author":"Pifl","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.09.008_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMc1107097","article-title":"Bath salts\" intoxication","volume":"365","author":"Ross","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2018.09.008_bib35","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00424-014-1487-1","article-title":"Excitation of rat sympathetic neurons via M1 muscarinic receptors independently of Kv7 channels","volume":"466","author":"Salzer","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuint.2018.09.008_bib36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-3565(24)39309-7","article-title":"Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter","volume":"293","author":"Scholze","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.09.008_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(01)02058-4","article-title":"Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters","volume":"309","author":"Scholze","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2018.09.008_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchemneu.2017.01.004","article-title":"Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter","volume":"83\u201384","author":"Shekar","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuint.2018.09.008_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2018.09.008_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2018.09.008_bib41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/mol.59.5.1129","article-title":"Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion","volume":"59","author":"Sitte","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.09.008_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \"bath salts\" and \"legal highs\" (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuint.2018.09.008_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00128-016-1869-5","article-title":"The presence of stimulant drugs in wastewater from Krakow (Poland): a snapshot","volume":"97","author":"Styszko","year":"2016","journal-title":"Bull. Environ. Contam. Toxicol."},{"key":"10.1016\/j.neuint.2018.09.008_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2018.09.008_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/FTD.0000000000000263","article-title":"The toxicology of new psychoactive substances: synthetic cathinones and phenylethylamines","volume":"38","author":"Tyrkko","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.neuint.2018.09.008_bib46","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05506.x","article-title":"Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice","volume":"106","author":"Vialou","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2018.09.008_bib47","doi-asserted-by":"crossref","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","article-title":"Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain","volume":"273","author":"Wu","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618303437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618303437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T18:37:43Z","timestamp":1751999863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018618303437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":47,"alternative-id":["S0197018618303437"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2018.09.008","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cPolytox\u201d synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}